A 5-year comparative imaging trial with glatiramer acetate versus low or high doses of other disease-modifying therapies in treatment-naive patients with relapsing-remitting multiple sclerosis.

Trial Profile

A 5-year comparative imaging trial with glatiramer acetate versus low or high doses of other disease-modifying therapies in treatment-naive patients with relapsing-remitting multiple sclerosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2011

At a glance

  • Drugs Glatiramer acetate; Interferon beta-1a; Interferon beta-1b
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2011 Planned End Date changed to 1 Dec 2007.
    • 11 Oct 2011 Final results of this 5-year brain MRI study have been published in the Journal of the Neurological Sciences, according to a Teva Neuroscience media release.
    • 22 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top